We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




‘Lab on a Chip’ Paves Way for Use of Portable Spectrometer in Biomedical Analysis

By LabMedica International staff writers
Posted on 24 Oct 2022
Print article
Image: Light-analyzing ‘lab on a chip’ opens door to widespread use of portable spectrometers (Photo courtesy of Oregon State University)
Image: Light-analyzing ‘lab on a chip’ opens door to widespread use of portable spectrometers (Photo courtesy of Oregon State University)

Scientists have developed a better tool to measure light, contributing to a field known as optical spectrometry and resulting in a powerful, ultra-tiny spectrometer that fits on a microchip and is operated using artificial intelligence (AI). Traditional spectrometers require bulky optical and mechanical components, whereas the new device could fit on the end of a human hair. The research involved a comparatively new class of super-thin materials known as two-dimensional semiconductors, and the upshot is a proof of concept for a spectrometer that could be readily incorporated into a variety of technologies – including biomedical analyzers, among others.

The new research by scientists at Oregon State University (Corvallis, OR, USA) and Aalto University (Espoo, Finland) suggests those components can be replaced with novel semiconductor materials and AI, allowing spectrometers to be dramatically scaled down in size from the current smallest ones, which are about the size of a grape. The device is 100% electrically controllable regarding the colors of light it absorbs, which gives it massive potential for scalability and widespread usability, the researchers say. In medicine, spectrometers are already being tested for their ability to identify subtle changes in human tissue such as the difference between tumors and healthy tissue.

“We’ve demonstrated a way of building spectrometers that are far more miniature than what is typically used today,” said Ethan Minot, a professor of physics in the OSU College of Science. “Spectrometers measure the strength of light at different wavelengths and are super useful in lots of industries and all fields of science for identifying samples and characterizing materials. It’s exciting that our spectrometer opens up possibilities for all sorts of new everyday gadgets, and instruments to do new science as well.”

“Our spectrometer does not require assembling separate optical and mechanical components or array designs to disperse and filter light,” said Hoon Hahn Yoon, Aalto University. “Moreover, it can achieve a high resolution comparable to benchtop systems but in a much smaller package.”

Related Links:
Oregon State University
Aalto University

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
C-Reactive Protein Assay
OneStep C-Reactive Protein (CRP) RapiCard InstaTest
New
Ultra-Low Temperature Freezer
iUF118-GX

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.